MIS416
id:
mis416-280-13498773
title:
MIS416
text:
MIS416 is an experimental drug developed by Innate Immunotherapeutics which underwent clinical trials to treat secondary progressive multiple sclerosis. It is derived from the bacteria that causes acne and targets myeloid cells through TLR9 and NOD2. In one of its first rounds of clinical trials, the drug was shown to be "safe and well tolerated", with 80% of secondary-progressive multiple sclerosis patients exhibiting more than 30% improvement in at least one area of their MS status. However, P
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/MIS416
date created:
date modified:
2022-10-03T03:47:49Z
main entity:
{"identifier":"Q56276945","url":"https://www.wikidata.org/entity/Q56276945"}
image:
fields total:
13
integrity:
13